SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nicole P. Bowles, Ilia N. Karatsoreos, Xiaosong Li, V. Kiran Vemuri, Jodi-Anne Wood, Zhiying Li, Kellie L. K. Tamashiro, Gary J. Schwartz, Alexandros M. Makriyannis, George Kunos, Cecilia J. Hillard, Bruce S. McEwen, Matthew N. Hill, A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome, Proceedings of the National Academy of Sciences, 2015, 112, 1, 285

    CrossRef

  2. 2
    S. Rodriguez-Cuenca, N. Barbarroja, A. Vidal-Puig, Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2015, 1851, 1, 40

    CrossRef

  3. 3
    Liane Rabinowich, Sigal Fishman, Einav Hubel, Tamar Thurm, Woo-Jae Park, Yael Pewzner-Jung, Ashish Saroha, Noam Erez, Zamir Halpern, Anthony H. Futerman, Isabel Zvibel, Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesity, Journal of Hepatology, 2015, 62, 1, 175

    CrossRef

  4. 4
    Luigia Cristino, Thorsten Becker, Vincenzo Marzo, Endocannabinoids and energy homeostasis: An update, BioFactors, 2014, 40, 4
  5. 5
    P.D. Cani, L. Geurts, S. Matamoros, H. Plovier, T. Duparc, Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond, Diabetes & Metabolism, 2014, 40, 4, 246

    CrossRef

  6. 6
    Woo-Jae Park, Joo-Won Park, Alfred H. Merrill, Judith Storch, Yael Pewzner-Jung, Anthony H. Futerman, Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014, 1841, 12, 1754

    CrossRef

  7. 7
    A. Chatzigeorgiou, E. Kandaraki, A. G. Papavassiliou, M. Koutsilieris, Peripheral targets in obesity treatment: a comprehensive update, Obesity Reviews, 2014, 15, 6
  8. 8
    Daniel J. Hermanson, Joyonna C. Gamble-George, Lawrence J. Marnett, Sachin Patel, Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation, Trends in Pharmacological Sciences, 2014, 35, 7, 358

    CrossRef